Photo of Troy A. Carter
D United States House · District 2 · Louisiana On the 2026 ballot

Rep. Troy A. Carter

Compare
Total votes
2,696
all sessions
Attendance
94%
159 missed
Near the chamber average
With party
98%
of cast votes
Higher than 84% of chamber peers
Bipartisan score
1%
crosses aisle rarely
Lower than 85% of chamber peers
Sponsored
1,556
bills & resolutions
Higher than 91% of chamber peers
Committees
7
assignments
1,556 bills and resolutions

Sponsored bills

Total
1,556
Primary
72
Co-sponsor
1,484
This page
1,556
matching current filters
Co-sponsor HR 9941
In committee · Florida House · Co-sponsor
Right to IVF Act of 2026

Maddy summaryThis bill establishes federal protections and funding to expand access to in vitro fertilization and intrauterine insemination for individuals, military service members, and veterans. It requires most private health plans, Medicaid programs, and Medicare to cover these fertility treatments without imposing higher cost-sharing than other medical services. Additionally, the legislation mandates that the Department of Defense and the Department of Veterans Affairs provide specific fertility preservation and treatment benefits to uniformed service members and eligible veterans. The bill also includes preemption clauses that override state laws restricting these procedures and prohibits discrimination based on marital status, sex, or sexual orientation in the provision of care.

In committee Jul 23, 2026 1 co-sponsor
Co-sponsor HR 9898
In committee · Florida House · Co-sponsor
Transportation for Reentry Act

Maddy summaryThe Transportation for Reentry Act requires transit agencies receiving federal funding to offer free public transportation to individuals released from prison after serving at least one year. Under this bill, these agencies must provide the service for one year starting from the person's release date and cover costs related to program setup, staff training, and outreach. To receive federal grants, transit recipients must establish enrollment systems, track usage data, and ensure compliance with the program's duration requirements. The legislation authorizes $40 million annually from 2027 to 2031 to support these efforts and mandates a final report on the program's impact five years after enactment.

In committee Jul 23, 2026 1 co-sponsor
Co-sponsor HR 8205
Passed · Florida House · Co-sponsor
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Maddy summaryThis bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.

Passed Jul 23, 2026 1 co-sponsor
Co-sponsor HR 9874
In committee · Florida House · Co-sponsor
Get Foreign Money Out of United States Elections Act

Maddy summaryThis bill expands federal election laws to prevent foreign nationals from influencing U.S. elections by tightening restrictions on domestic companies with significant foreign ownership or control. It requires businesses that are at least 50% owned by foreign individuals, or those with specific foreign influence, to file a sworn certification proving they are not foreign-controlled before making any political donations or spending money on election activities. Additionally, the law clarifies that these rules apply to state and local ballot initiatives and mandates that corporate political action funds certify their managers and board members are U.S. citizens or permanent residents. The legislation also prohibits recipients of funds from these businesses from using the money for further political contributions unless they receive and verify the required compliance certification.

In committee Jul 22, 2026 1 co-sponsor
Co-sponsor HR 9849
In committee · Florida House · Co-sponsor
Tuskegee Airmen Memorial Act of 2026

Maddy summaryThe Tuskegee Airmen Memorial Act of 2026 authorizes the organization Tuskegee Airmen, Inc. to build a commemorative monument on federal land in Washington, D.C., honoring the original Tuskegee Airmen who served in World War II. This legislation allows the group to accept private donations and cover all costs for the project without using federal funds, while requiring any leftover money to be deposited into specific government accounts. The bill also mandates that the memorial be constructed in compliance with existing federal standards for commemorative works.

In committee Jul 22, 2026 1 co-sponsor
Co-sponsor HR 9847
In committee · Florida House · Co-sponsor
Improving CARE for Youth Act

Maddy summaryThe Improving CARE for Youth Act modifies Medicaid rules to allow payment for mental health, substance use disorder, and primary care services provided on the same day within the same clinic or health center. This change directly affects youth and adults receiving care by removing previous restrictions that often prevented billing for these combined visits. The bill defines "same-day qualifying services" to include scenarios where a patient sees both a primary care provider and a mental health specialist in one visit, or vice versa, at facilities like Federally qualified health centers or physician offices. By updating the Social Security Act, the legislation aims to streamline access to coordinated care without imposing new limitations on how these services are billed.

In committee Jul 22, 2026 1 co-sponsor
Primary HR 9842
In committee · Florida House · Lead sponsor
State Offices of Women’s Health Support and Expansion Act

Maddy summaryThis bill establishes a federal grant program to help states create or maintain dedicated offices focused on women's health. The funding, totaling $55 million annually from 2027 to 2031, is split evenly between all states and a formula based on factors like maternal mortality and poverty rates. Recipients must use the money for public education, data collection, and addressing social issues like housing and food insecurity, while also forming community advisory panels. The legislation includes strict rules prohibiting the use of funds to discourage reproductive health services and mandates strong privacy protections for any data collected.

In committee Jul 22, 2026 0 co-sponsors
Co-sponsor HR 9808
In committee · Florida House · Co-sponsor
No Passes for Polluters Act of 2026

Maddy summaryThe No Passes for Polluters Act of 2026 requires Congress to explicitly approve any exemptions from Clean Air Act regulations before the President or federal agencies can use them. Under this bill, the President must submit a detailed message to both houses of Congress explaining the reasons and facts behind any proposed exemption, which then triggers a special legislative process. To pass such an exemption, a joint resolution must be approved by a two-thirds vote in both the Senate and the House of Representatives, with limited debate and no amendments allowed. Additionally, the Comptroller General will review these proposals to ensure they have legal authority, and any unauthorized use of exemptions could lead to civil lawsuits. The legislation also mandates that the President reconsider certain executive branch emissions regulations every three years.

In committee Jul 21, 2026 1 co-sponsor
Co-sponsor HR 2821
Passed · Florida House · Co-sponsor
FDA Modernization Act 3.0

Maddy summaryHR 2821, the FDA Modernization Act 3.0, requires the FDA to update regulatory language within one year of enactment. It directs the agency to replace all references to "animal tests" with "nonclinical tests" in 22 specific sections of the Code of Federal Regulations related to drug development and approval processes. The bill also adds a definition for "nonclinical test" into relevant FDA regulations to align with prior legislative changes. This update applies directly to pharmaceutical manufacturers and FDA reviewers who follow these regulatory guidelines during drug development. The changes aim to modernize terminology without altering current testing requirements.

Passed Jul 21, 2026 1 co-sponsor
Showing 21 to 30 of 1,556 bills
Previous 1 2 3 4 156 Next